Table 2.

FMT therapeutic perspectives in melanoma patients.

Youngster et al. 2019 [53]	Five patients with melanoma resistant to therapy FMT via gastroscopy and colonoscopy After treatment, three patients out of five recovered sensitivities to treatment and presented a response to immunotherapy
Davar et al. 2021 [55]	Included 15 patients with advanced melanoma resistant to immunotherapy Patients received FMT every 14 days with pembrolizumab Six patients diminished their tumors/ stabilized their disease
Baruch et al. 2021 [56]	Included 10 patients with refractory melanoma Received FMT from two allogenic donorsThree patients recovered immunotherapy response One patient presented a total response to nivolumab Two patients presented a partial response